Patrinia heterophylla Bunge, a traditional Chinese herb, has long been used for therapy of many kinds of diseases, including cancer. Its extract or pure compound has displayed anti-proliferative effect on cancer cells as well. However, the underlying mechanism(s) by which P. heterophylla Bunge exhibited anti-tumor activity in vivo remains to be further elucidated. Herein, we investigated the effect of total flavonoid from P. heterophylla Bunge, named as PHBF, on mice bearing cervical cancer. As a result, the oral administration of PHBF (250 and 500 mg/kg BW) had significant inhibitory effect on tumor volume and weight. In addition, PHBF treatment increased thymus index of tumor-bearing mice in a dose-dependent manner (P<0.01). Further analysis revealed that cervical cancer cell from tumor-bearing mice treated with PHBF underwent significant apoptosis, which was accompanied by the decrease of PCNA and Bcl-2 expression and increase of Bax and cleaved caspase 3 expression. Interestingly, PHBF treatment also induced more CD4 + and CD8 + T lymphocytes in peripheral blood mononuclear cells (PBMC) of tumor-bearing mice. Furthermore, we observed that the serum level of interferon gamma (IFN-γ) and interleukin-2 (IL-2) was significant higher in mice treated with PHBF than those of control group, implicating that PHBF could function as an immunomodulatory agent. Taken together, these data suggested that PHBF harbored anti-tumor properties against cervical cancer and up-regulated immune response, therefore paving a path to develop as a potential therapeutic and preventive agent for cervical treatment.
Cancer is the main cause of death worldwide, and management of cancer progression using current chemotherapeutic drugs has shown to be limited in efficacy and safety. Medical plants serving as a novel or alternative cancer therapy method with little side-effect on patients have been paid more attention over the past two or three decades in China, South Korea, Japan, United States, etc. Increasing evidences showed that many bioactive compounds derived from plants exerted anti-proliferative or tumor-suppressive activity [1] . Of those components, flavonoid is a heterogeneous group of ubiquitous polyphenol compounds that abound in plants, many of which have been identified as potential drugs to broadly prevent or inhibit tumor growth [2] . Due to the ability to directly inhibit proliferation and induce apoptosis of cancer cells, some flavonoids have been well investigated in vitro and in vivo, including daidzein, luteolin, apigenin, quercetin, genistein and catechin [3, 4] , etc. On the other hand, there were also some evidences that flavonoids are involved in amelioration of oxidative stress and immunosuppression [5] .
Due to the development of neoplastic diseases, severe immunosuppression usually occurs to patients. Evidences show that tumors not only decrease the reactivity of circulation T cells, but also could induce T cell apoptosis, resulting in the suppression of cell-mediated immune function [6] . However, the majority of chemotherapeutic agents exert their antitumor effects through anti-proliferative and cytotoxic actions, with the same mechanism of which the host defense system, one of the most highly proliferative systems of body, is also inhibited by those agents. Nevertheless, the fact that anticancer drugs may augment immune response has been documented since the middle period of last century. Moreover, there are increasing evidences that the combination of conventional chemotherapeutic agents with bioactive compounds serving as chemoadjuvants generates additive anti-cancer effect and less side-effect [7] . Therefore, finding alternative antineoplastic drugs with ability to cause immunoaugmentation would be a novel approach against cancer.
Patrinia heterophylla Bunge (Chinese name: Mutouhui) is herbaceous plant found in Asia, and has long been being used as a traditional Chinese medicine. Recent studies have demonstrated that extracts of P. heterophylla Bunge could possess potent cytotoxicity and anti-tumor activity [8, 9] . Yang, et al. showed that extract from P. heterophylla Bunge could induce apoptosis in PC-3 cells [10] . However, the role of flavonoid fractions from P. heterophylla Bunge in tumor suppression and immunomodulation has not been established yet in vivo. In the current study, we isolated and purified flavonoid from P. heterophylla Bunge, named as PHBF, and then assessed its antitumor and immunomodulatory activities using a U14 cell bearing mouse model. We found PHBF treatment contributes to the reduction in tumor load which could be resulted from increased apoptosis. Meanwhile, PHBF exerts immunomodulatory effect on tumor-bearing mice, thus being beneficial for tumor suppression. Figure 1 A and B, PHBF treatment caused a dose-dependent reduction in tumor size and weight with the inhibition ratios of 35.2% and 50.8% at doses of 250 and 500 mg/kg, respectively (P<0.05). Nevertheless, the inhibitory rate was still lower than that resulted from CTX treatment (66.1%). Meanwhile, the body weight of tumor-bearing mice was not affect by PHBF treatment (27.8 ± 2.2 g for 250 mg/kg group and 28.4 ± 1.9 g for 500 mg/kg group), however, was significantly decreased due to CTX treatment(23.7 ± 1.5 g) (Figure1C).Thymus index is closely related to immune function. On the 16th day after tumor inoculation, thymus from various groups of mice were dissected aseptically and weighed precisely. Thymus index in PHBF treatment groups markedly increased compared with the control group (10.8±1.4 mg/10 g, and 12.3±2.2 mg/10 g, vs. 7.3±1.5 mg/10 g, P<0.05). While, compared with control group, thymus index of CTX treated group decreased significantly (4.2±1.3 mg/10 g) ( Figure 1D ).
Effect of PHBF on tumor growth and immune organ: As shown in

Effect of PHBF on tumor cell apoptosis:
To further understand the mechanism by which PHBF inhibited tumor growth, we asked whether PHBF directly induced tumor cell apoptosis. Using Annexin V/PI staining assay, the data showed that the apoptotic rate of tumor cells harvested from mice treated with PHBF (22.6±4.2% for 250mg/kg group, 48.0±9.9% for 500mg/kg group) was dramatically elevated compared with that of vehicle treatment (6.1±2.0%) (Figures 2A and B) . Moreover, the expression of PCNA, a typical marker of tumor proliferation, was markedly decreased after PHBF treatment as shown in Figure 2C and D. Besides, the ratio of anti-apoptotic proteins (Bcl-2) to pro-apoptotic proteins (Bax) was significantly altered, as well as the increased cleavage of caspase 3 protein was detected due to the oral administration of PHBF, suggesting apoptosis pathway was activated ( Figure 2C and D), which further supported our observation that tumor cell underwent apoptosis in group of PHBF treatment.
Effect of PHBF on the distribution of T cells subpopulation in PBMC:
Given that PHBF treatment increased thymus index, which are closely associated with maturation of T cells. Mature T cells mainly differentiate into CD4 + and CD8 + cells, both of which play critical roles in immune system. We next analyzed the CD4 + and CD8 + subpopulations of peripheral blood mononuclear cells. As shown in Figure3, there was 1.6 and 2.6 fold increase in the percentage of CD8 + T cells after dose-dependent PHBF treatment, respectively, compared to control group. Although CD4 + T cells were also improved in tumor-bearing mice treated with PHBF, there was no dose-dependent trend. On the contrary, CTX serving as Antitumor properties of Patrinia heterophylla Natural Product Communications Vol. 12 (7) 2017 1071
Effect of PHBF on serum cytokine levels in tumor bearing mice:
Next, we investigated the effect of PHBF on IFN-γ, IL-2, TNF-α and IL-10 levels in U14 tumor-bearing mice. As seen in Figure 4 , compared with the control group, PHBF promoted the level of serum IL-2 and IFN-γ (P<0.05). Meanwhile, there was no significant change in the level of TNF-α and IL-10 (P>0.05) between vehicle and PHBF treatment (Figure4) .
The root and rhizome of P. heterophylla, which belong to family Caprifoliaceae, are usually used as Chinese herb, namely Mutouhui. It functions dissipating heat and detoxification, activating blood flow, drying dampness and curing leukorrhagia, and also treats cervical cancer and gastric cancer in folk medicine. Chemically, the main components could be flavonoid, triterpenoid saponin, volatile oil, etc. Flavonoids found in vegetables and herbs have been well documented in terms of inhibition of tumor angiogenesis, induction of apoptosis and cell cycle arrest, immunomodulation as well as clearance of superoxide and radicals. Studies have also demonstrated that flavonoids produced significant anti-nociceptive and anti-inflammatory activities [11] . These actions make it possible that flavonoids exhibit tumor-suppressive effect through multiple pathways. Moreover, recent evidence showed that the combination of genistin from soybean with epigallocatechin gallate promoted tumorigenesis, which is opposite to the effect of each compound alone [12] . Thus, the application of flavonoids from different herbs toward cancer treatment remained to be further investigated.
It is well known that the adaptive immune system, not only responds to infection, but it also monitors their tissue for the presence of cancer cell [13] . Therefore, activating or enhancing the powers of patients' immune systems to mount an attack against tumors that they carry would facilitate the inhibition of tumor growth. The thymus plays an important role in the functioning of the immune systems, where T lymphocytes mature. T cells are involved in the process of tumor initiation, development, and metastasis inhibition. They can differentiate into T helper cells (CD4 + T cells) and cytotoxic T cells (CD8 + T cells), both of which play critical roles in anti-tumor immunity. With the help of activated CD4 + T cells, CD8 + T cells migrate to the tumor site and induce cell apoptosis through releasing perforin and granzymes or activating FasL/Fas pathway [14] . However, conventional chemotherapeutic agents would destroy host immune system and induce T cells death, resulting in lots of side effect [15] . We demonstrated that PHBF could suppress tumor growth accompanied with improvement of T cells subsets (Figure 3 ), which was in agreement with previous reports about the immunomodulatory effect of flavonoids of plant extract. Nevertheless, whether PHBF treatment was able to enhance CD8 + T cells invaded into tumor remains unclear.
It is believed that the occurrence of human papillomavirus (HPV)induced cervical cancer is strongly associated with not only lack of CD8 + T cell migrating into tumor, but also impaired CD4 + T cell immunity. Currently, CD4 + T lymphocytes are mainly classified as Th1, Th2, and Th17 subsets, according to the type of cytokines secreted. Th1 cells mainly secrete IL-2 and IFN-γ, which can facilitate tumor growth inhibition via promoting CTL response. In contrast, Th2 cells mainly secrete IL-4, and IL-10, which are involved in humoral immune and allergic reactions and have been shown to promote tumor growth by stimulating cell proliferation or conferring tumor cell resistance to apoptosis [16] . Apparently, these subsets exerted differential functions during tumor development. Our data showed that the level of IFN-γ and IL-2 was increased due to PHBF treatment (Figure 4) , implicating that Th1 subset was activated and functioned as tumor-suppressive activity. However, the detailed distribution of CD4 + T cell subsets needed to be further investigation.
Consistent with its immunomodulatory activity, PHBF treatment inhibited tumor growth in a dose-dependent manner. These data are in agreement with previous studies that flavonoids can induce tumor cell apoptosis and suppress the tumor growth in the other types of carcinoma [10, 17] . Further investigation showed PHBF dramatically induce tumor cell apoptosis as evidenced with the alteration of Bax/Bcl-2 ratio and the cleavage of caspase 3. Yang et al. has reported that isovaltrate acetoxyhydrin from P. heterophylla could trigger mitochondria-related apoptotic pathway in gastric cancer cells [18] . It is still obscure that PHBF-induced apoptosis in U14 tumor cells is mainly attributed to its bioactive compound-mediated cytotoxic effect or its immunomodulatory activity.
Taken together, PHBF could not only inhibit tumor cell proliferation and induce apoptosis, but more importantly modulate immune function on tumor-bearing mice. Interestingly, the fact that PHBF exhibited anti-proliferative effect on tumor cells; while promoting immune response in tumor-bearing mice provides evidence for treatment of cervical cancer with P. heterophylla. In addition, the immunomodulatory activity of PHBF could lead to more beneficial result during long-term trial of cancer therapy or potentiate its cancer preventive activity. Nevertheless, further elucidation of mechanism would be necessary before using clinically.
Experimental
Cell lines and Reagents:
Uterine cervical carcinoma (U14) cell line, Chinese Academy of Medical Sciences (Beijing, China); Cyclophosphamide (CTX), Jiangsu Hengrui Medicine Co., (Lianyungang, China); Antibodies against PCNA, Bcl-2, Bax, cleaved caspase 3, GAPDH, Santa Cruz Biotechnology (Dallas, USA); Enzyme linked immunosorbent assay (ELISA) kits used for determining the mouse serum level of IFN-γ, IL-2, IL-10 and TNF-α, Bioworld technology Co., (Nanjing, China); PE-conjugated anti-mouse CD4 and FITCconjugated anti-mouse CD8, eBioscience, Inc.(San Diego, USA).
Preparation of PHBF:
The herbs (Patrinia heterophylla Bunge) were commercially purchased from Huadong Medicine Co., Ltd. The originally producing place was Shaanxi Province, China. The crude extract was prepared according to previously optimized method [19] . The extracts were then subjected to H103 macroporous adsorption resin column chromatography using 60% ethanol as eluent for further purification. The eluent liquid was pooled and freeze-dried. The total flavonoid content was determined by the method described in the Chinese Pharmacopoeia (Chinese Pharmacopoeia Committee, 2005), and the extracts contained 10.42 mg/g total flavonoids.
Animal studies: Female Kunming mice were obtained from the Experimental Animal Center of Xiehe Medical University (Beijing, China). They were fed with a standard pellet diet and water under temperature-controlled room (20±2 °C). Animal experiment was carried out according to Guide for the Care and Use of Laboratory Animals with approval of the Animal Ethics Committee of the university. Mice weighing 22.0±0.8 g were randomly divided into four groups consisting of 8 mice per group. Mice bearing tumor were generated as described in previous reports [20] . PHBF was orally administered at a dose of 250 mg/kg BW and 500 mg/kg BW respectively. The control group was treated with water. We also maintained another group treated with cyclophosphamide (CTX, 25 mg/kg BW, i.p.) as the standard reference drug. Treatments were continued for 15 days, and body weights as well as tumor volume were recorded every three days. On the 16th day, mice were weighed and euthanized, and tumors and thymus were removed and the weight measured. Thymus index was calculated as follow: thymus index = thymus weight (mg) / body weight (g) ×10; Tumor volume was calculated using the following formula: tumor volume (mm 3 ) = d 2 D/2, where d and D were the shortest and the longest diameter, respectively.
Flow cytometer analysis:
The harvested tumor were minced to prepare single cell suspension with 200 mesh filter, and then centrifuged at 1,000 rpm for 5 min. After washing three times with PBS, the concentration was adjusted to 1×10 6 cells/mL, fixed with 70% ethanol for overnight at -20°C. After washing with 70%, 50%, 20% ethanol and then PBS, cells were stained with FITCconjugated Annexin-V and propidium iodide (PI) (KeyGEN Biotech., Nanjing, China) containing RNase staining, and subjected to flow cytometer (BD Bioscience, San Jose, CA, USA) equipped with Muhicycle software. For flowcytometric analysis of peripheral blood mononuclear cells (PBMC), peripheral blood of mice were collected into heparin tube spray-coated with K 2 EDTA. Erythrocyte lysing solution was added into freshly-collected blood (1:10 v/v) and then centrifuged at 1000 rpm for 5 min. After removing red suspension, cells were washed with PBS followed by incubating with FITC-conjugated anti-mouse CD8 and PE-conjugated antimouse CD4 in dark over 1h at room temperature. Then cells were detected using flow cytometer as described above.
Enzyme-linked immunosorbent assay (ELISA):
Before execution, the blood of tumor-bearing mice of all groups were collected in Eppendorf tubes, deposited for 1h at 4 °C and centrifuged for 15 min at 3000 rpm, then the serum was collected and the level of IFNγ, IL-2, IL-10 and TNF-α was examined with ELISA assay kits according to the instructions of manufacturer.
Western blot analysis:
Tumor lysates were harvested using RIPA buffer solution complemented with proteinase inhibitors cocktail (Calbiochem). After determining the concentration through BCA assay (Pierce), 30µg of lysates were denatured and then subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by being transferred to PVDF membrane, which was subsequently blocked with Tris-buffer solution (TBS) containing 0.05% Tween-20 (TBS-T) and 5% skim milk. After that, the membrane was incubated with specific antibodies diluted in TBS-T with 5% non-fat milk at 4℃ overnight. After three washes with TBS-T, the membrane was incubated with HRPconjugated immunoglobulin G for 1 h at room temperature, visualized using ECL (Beijing CellChip Biotechnology Co., Ltd, Beijing, China).
Statistical analysis:
The data was represented with mean values ± standard deviation (n=3). Results were evaluated for statistical significance using one-way ANOVA followed by Tukey's multiple comparison test by SPSS V.14 (SPSS Inc., Chicago, USA). The confidence level for statistical significance was set at a probability value of 0.05 (P<0.05).
